Prednisolone acetate 50 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenu...
FDA Drug Recall #D-0124-2015 — Class II — August 27, 2014
Recall Summary
| Recall Number | D-0124-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 27, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Martin Avenue Pharmacy, Inc. |
| Location | Naperville, IL |
| Product Type | Drugs |
| Quantity | 55 mL |
Product Description
Prednisolone acetate 50 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
Reason for Recall
Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.
Distribution Pattern
Nationwide
Lot / Code Information
Lot Number: 05082014@23, Exp 11/4/2014
Other Recalls from Martin Avenue Pharmacy, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0118-2015 | Class II | Phentolamine mesylate 5 mg/35 mg/mannitol tritu... | Aug 27, 2014 |
| D-0130-2015 | Class II | Quad mix, 9 mg/1 mg/10 mcg/0.1 mg/mL (papaverin... | Aug 27, 2014 |
| D-0086-2015 | Class II | Hyaluronidase injection solution (PF) 150 U/mL ... | Aug 27, 2014 |
| D-0063-2015 | Class II | Benzalkonium chloride water for injection packa... | Aug 27, 2014 |
| D-0094-2015 | Class II | Hydroxyzine hydrochloride 25 mg/mL injectable p... | Aug 27, 2014 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.